Cargando…
Significant receptor affinities of metabolites and a degradation product of mometasone furoate
Mometasone furoate (MF) is a highly potent glucocorticoid used topically to treat inflammation in the lung, nose and on the skin. However, so far no information has been published on the human glucocorticoid receptor activity of the metabolites or degradation products of MF. We have now determined t...
Autores principales: | Valotis, Anagnostis, Högger, Petra |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC499542/ https://www.ncbi.nlm.nih.gov/pubmed/15285788 http://dx.doi.org/10.1186/1465-9921-5-7 |
Ejemplares similares
-
Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate
por: Valotis, Anagnostis, et al.
Publicado: (2007) -
Suppression of Cytokine Release by Fluticasone Furoate vs. Mometasone Furoate in Human Nasal Tissue Ex-Vivo
por: Zhang, Nan, et al.
Publicado: (2014) -
Efficacy of mometasone furoate and fluticasone furoate on persistent allergic rhinoconjunctivitis
por: Aneeza, W. Hamizan, et al.
Publicado: (2013) -
Mometasone furoate in the management of asthma: a review
por: Tan, Ricardo A, et al.
Publicado: (2008) -
Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease
por: Kosoglou, Teddy, et al.
Publicado: (2013)